Eli Lilly
4,622
$169.139876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$169.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.38 (+1.43%) Today
$0.00 (0.00%) As of 7:29 AM EDT after-hours
Why Robinhood?
You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!
About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. Read More The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
Employees
33,625
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
161.86B
Price-Earnings Ratio
27.62
Dividend Yield
1.66
Average Volume
3.37M
High Today
$169.82
Low Today
$166.84
Open Price
$166.84
Volume
2.78M
52 Week High
$169.82
52 Week Low
$101.36
Collections
LLY News
Benzinga21h
Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lilly's CDK 4 and 6 Inhibitor, Abemaciclib, in Metastatic Breast Cancer
COLUMBUS, Ohio, July 08, 2020 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female
Analyst Ratings
50%
of 16 ratings
Buy
50%
Hold
44%
Sell
6%
LLY Earnings
$0.00
$0.58
$1.17
$1.75
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Jul 30, Pre-Market